Crystal Meth Withdrawal
Crystal meth, also known as methamphetamine, is a very powerful man-made stimulant drug that has become increasingly popular with drug abusers.
This is because it can be made with very simple ingredients that can be purchased at drug stores.
Methamphetamine presents as small bluish and whitish rocks or as small pieces of glass, and is highly addictive. It is known by a number of street names including glass, ice, crank, shards, etc. The drug is typically snorted or smoked.
Withdrawal from Crystal MethThere are numerous studies that have documented the effects of withdrawal in chronic methamphetamine abusers. Despite quite a bit of misinformation online, it appears that the timeline for methamphetamine withdrawal is relatively consistent and offers some predictability regarding what clinicians and those in recovery can expect.
Withdrawal symptoms are primarily psychological and emotional with several associated physical symptoms. The withdrawal process from methamphetamine does not appear to be consistently severe, such as with withdrawal from alcohol or opioid drugs.
Withdrawal from crystal meth is most likely not potentially physically damaging unless the individual becomes extremely emotionally unstable and engages in self-harm.
- It begins within the first 24 hours of abstinence.
- It reaches its peak within the first 7-10 days following discontinuation of the drug, and there is a steady decline in the intensity of symptoms following this peak.
- It has an average duration of about 14-20 days, with 14 days being the most commonly reported duration of the withdrawal syndrome.
According to the same research and several other studies, it appears that the primary symptoms during this withdrawal period consist of:
- Feelings of fatigue, lethargy, and excessive sleepiness (typical of withdrawal from stimulant medications) are common.
- Increased appetite, dry mouth, and some episodes of jitteriness generally occur.
A significant number of individuals report feelings of depression, which were also noted to decline in a linear fashion over the course of the withdrawal time period. These depressive symptoms can be significant and associated with thoughts of suicide. In addition, research has indicated that a good number of individuals who relapse do so because of feelings of depression, apathy, hopelessness, etc.
Extreme cravings for methamphetamine also occur during the withdrawal process but have been noted to decline rapidly. Cravings for methamphetamine during withdrawal appear to be associated with the level of depression occurring in the individual. In addition, as one would expect, research indicates that the more intense and frequent the cravings an individual in withdrawal from methamphetamine experiences, the higher the probability that the individual will relapse during the withdrawal syndrome.
Psychotic symptoms, such as paranoia, hallucinations, and delusions, also occur in many individuals. These symptoms need to be addressed in a professional treatment environment.
Medications to Assist in the Withdrawal ProcessThere are no medications approved by the FDA that are specifically designed to be used in the detox withdrawal process from crystal meth. However, there are several different medications that can help to manage some of the symptoms that occur during this process of withdrawal:
Wellbutrin (bupropion): This drug is an antidepressant that has been approved for and used in smoking cessation programs. It also has a good body of research indicating that it is useful in reducing the symptoms of withdrawal in individuals who have abused crystal meth. It appears to reduce the significant cravings associated with the withdrawal process and appears to be more appropriate for light to moderate methamphetamine use disorders.
Provigil (modafinil): This medication is a mild stimulant medication that is used in the treatment of ADHD and in the treatment of narcolepsy. The mild stimulant properties of the medication can assist in reducing issues of with disruptive sleep patterns and may also help those in recovery with increasing energy and enhancing concentration.
Selective serotonin reuptake inhibitors: Paxil (paroxetine) is a selective serotonin reuptake inhibitor (a specific type of antidepressant medication) that has been shown in some studies to relieve cravings in abstinent crystal meth users going through withdrawal; however, the research on the efficiency of this drug for treatment during crystal meth withdrawal is mixed. There is research that has suggested that Prozac (fluoxetine) may be useful in the treatment of crystal meth addiction during the withdrawal process.
Remeron (mirtazapine): Remeron is an atypical antidepressant that has its primary mechanism of action on both serotonin and norepinephrine. There is evidence that its use can help to prevent relapse during the withdrawal process.
Explore Meth Addiction and Treatment
Start The Admissions Process Now
Your 1-on-1 consultation and Insurance Verification are 100% Free
All you have to do is pick up the phone and call or chat now
We will never share your information with a third party without your explicit consent